|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
30988764X |
| 003 |
DE-627 |
| 005 |
20230905074052.0 |
| 007 |
tu |
| 008 |
000214s1999 sw ||||| m 00| ||eng c |
| 020 |
|
|
|a 9155445500
|9 91-554-4550-0
|
| 035 |
|
|
|a (DE-627)30988764X
|
| 035 |
|
|
|a (DE-576)088681971
|
| 035 |
|
|
|a (DE-599)GBV30988764X
|
| 035 |
|
|
|a (OCoLC)247719544
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XA-SE
|
| 084 |
|
|
|a 44.42
|2 bkl
|
| 100 |
1 |
|
|a Hultén, Johan
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Cyclic sulfamides as HIV-1 protease inhibitors
|b synthesis, X-ray structure analysis and structure-activity relationship
|c Johan Hultén
|
| 264 |
|
1 |
|a Uppsala
|b AUU
|c 1999
|
| 300 |
|
|
|a 72 S
|b Ill
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 490 |
1 |
|
|a Comprehensive summaries of Uppsala dissertations from the Faculty of Pharmacy
|v 213
|
| 502 |
|
|
|a Zugl.: Uppsala, Univ., Diss., 1999
|
| 655 |
|
7 |
|a Hochschulschrift
|0 (DE-588)4113937-9
|0 (DE-627)105825778
|0 (DE-576)209480580
|2 gnd-content
|
| 689 |
0 |
0 |
|D s
|0 (DE-588)4392890-0
|0 (DE-627)190491884
|0 (DE-576)211965537
|a Sulfamidderivate
|2 gnd
|
| 689 |
0 |
1 |
|D s
|0 (DE-588)4200792-6
|0 (DE-627)10410497X
|0 (DE-576)210137967
|a HIV
|2 gnd
|
| 689 |
0 |
2 |
|D s
|0 (DE-588)4130450-0
|0 (DE-627)104805889
|0 (DE-576)209619112
|a Proteaseinhibitor
|2 gnd
|
| 689 |
0 |
|
|5 (DE-627)
|
| 751 |
|
|
|a Uppsala
|4 uvp
|
| 810 |
2 |
|
|a Uppsala Universitet
|b Farmaceutiska Fakulteten
|t Comprehensive summaries of Uppsala dissertations from the Faculty of Pharmacy
|v 213
|9 213
|w (DE-627)129583227
|w (DE-576)017406641
|w (DE-600)233135-4
|x 0282-7484
|7 ns
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a ISIL_DE-84
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OPC-PHA
|
| 912 |
|
|
|a SSG-OPC-DE-84
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a ISIL_DE-7
|
| 912 |
|
|
|a GBV_ILN_62
|
| 912 |
|
|
|a ISIL_DE-28
|
| 936 |
b |
k |
|a 44.42
|j Pharmazeutische Chemie
|0 (DE-627)18157179X
|
| 951 |
|
|
|a BO
|
| 980 |
|
|
|2 20
|1 01
|x 0084
|b 380703882
|c 00
|f --%%--
|d 2786-1277
|e --%%--
|j --%%--
|y k
|z 28-02-00
|
| 980 |
|
|
|2 40
|1 01
|x 0007
|b 37876084X
|c 00
|f --%%--
|d K 2000 A 529
|e u
|j --%%--
|y xsn
|z 13-03-00
|
| 980 |
|
|
|2 62
|1 01
|x 0028
|b 515714070
|c 00
|f 28/BB1-MAG
|d ZA 6442 (213)
|e u
|j --%%--
|c 05
|f --%%--
|d VR 3100 C737-213
|e --%%--
|j --%%--
|y zbb1d
|z 12-09-01
|
| 984 |
|
|
|2 20
|1 01
|x 0084
|a 84$027861277
|
| 984 |
|
|
|2 40
|1 01
|x 0007
|a 7$210528664
|
| 984 |
|
|
|2 62
|1 01
|x 0028
|a 28$00442168X
|
| 985 |
|
|
|2 62
|1 01
|x 0028
|a ZA 6442 (213)
|
